Trends in Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease Underlying-Cause Mortality in the United States, 1999–2023
ASIDE Gastroenterology · 2026
DOI: 10.71079/aside.gi.091126632 ↗Abstract
Background: Alcoholic liver disease (ALD) and nonalcoholic fatty liver disease (NAFLD) are major drivers of liver-related mortality in the United States, but comparative long-term trends remain unclear. Methods: We analyzed U.S. mortality data (1999–2023) from the CDC WONDER Underlying Cause of Death database. ALD (ICD-10 K70.x) and NAFLD (K75.8, K76.0) deaths were identified. Age-adjusted mortality rates (AAMRs) per 100,000 were calculated, and Joinpoint regression estimated annual percent change (APC) with 95% confidence intervals (CI). Results: ALD mortality rose from 6.71 in 1999 to 11.47 in 2023. Rates declined slightly in 1999–2006 (APC –0.51%; p=0.25), then increased from 2006–2018 (APC 3.24%; p
EUVIMED